Boston Scientific Corp. vs. Orchestra BioMed Holdings, Inc. Ordinary Shares
BSX
Boston Scientific Corp.
$44.98 -5.90%
VS OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares
$5.41 -0.38%
Boston Scientific Corp. and Orchestra BioMed Holdings, Inc. Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BSX | OBIO | |
|---|---|---|
| Market Cap | $65.19 billion | $326.37 million |
| Revenue (TTM) | $21.00 billion | — |
| Net Income (TTM) | $3.67 billion | — |
BSX leads on 1 of 1 size & scale factors.
Valuation
| BSX | OBIO | |
|---|---|---|
| P/E Ratio | 18.21 | — |
| Price / Book | 2.59 | — |
| Price / Sales | 3.10 | — |
BSX and OBIO split the valuation factors evenly.
Profitability
| BSX | OBIO | |
|---|---|---|
| Net Margin | 17.47% | — |
| Return on Equity | 14.58% | — |
BSX and OBIO split the profitability factors evenly.
Risk & Sentiment
| BSX | OBIO | |
|---|---|---|
| Short Interest | 0.72% | 0.05% |
OBIO leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, OBIO overview, OBIO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.